Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

NCT00082498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: SCH-D (vicriviroc)
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]